Biomarker-driven drug repurposing on biologically similar cancers with DNA-repair deficiencies
Similar molecular and genetic aberrations among diseases can lead to the discovery of jointly important treatment options across biologically similar diseases. Oncologists closely looked at several hormone-dependent cancers and identified remarkable pathological and molecular similarities in their D...
Main Authors: | Seeya Awadhut Munj, Tasnimul Alam Taz, Suzan Arslanturk, Elisabeth I. Heath |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.1015531/full |
Similar Items
-
Homologous Recombination Repair Deficiency and Implications for Tumor Immunogenicity
by: Sandra van Wilpe, et al.
Published: (2021-05-01) -
Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision Oncology
by: Alexander M. A. van der Wiel, et al.
Published: (2022-08-01) -
Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype
by: Sandra van Wilpe, et al.
Published: (2022-12-01) -
Interactions between miRNAs and Double-Strand Breaks DNA Repair Genes, Pursuing a Fine-Tuning of Repair
by: Ricardo I. Peraza-Vega, et al.
Published: (2022-03-01) -
Landscape of homologous recombination deficiencies in solid tumours: analyses of two independent genomic datasets
by: Zhongwu Lai, et al.
Published: (2022-01-01)